Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients
Ann Transl Med
.
2020 Dec;8(24):1696.
doi: 10.21037/atm-20-4725.
Authors
Maria Alsina
1
,
Elizabeth C Smyth
2
Affiliations
1
Department of Medical Oncology Vall d'Hebron University Hospital and VHIO Vall d'Hebron Insitute of Oncology, Barcelona, Spain.
2
Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
PMID:
33490208
PMCID:
PMC7812199
DOI:
10.21037/atm-20-4725
No abstract available
Publication types
Editorial
Comment